Kobe City Medical Center General Hospital; Hematology

Hyōgo 650-0047

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma

Studies at this site

• A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) — Completed
• A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) — Stopped early